Editorial: symposium on nuclear imaging in dementia and depression.
作者信息
Wyper David
出版信息
Nucl Med Commun. 2005 Mar;26(3):181-2. doi: 10.1097/00006231-200503000-00001.
Abstract
摘要
相似文献
1
Editorial: symposium on nuclear imaging in dementia and depression.
Nucl Med Commun. 2005 Mar;26(3):181-2. doi: 10.1097/00006231-200503000-00001.
2
Nuclear medicine for all the world--from molecular imaging to molecular medicine.
J Korean Med Sci. 2007 Aug;22(4):595-7. doi: 10.3346/jkms.2007.22.4.595.
3
Evaluating pathology in the brain with nuclear medicine.
Semin Nucl Med. 2008 Jul;38(4):225-6. doi: 10.1053/j.semnuclmed.2008.03.002.
4
Society of Nuclear Medicine--54th annual meeting. New directions in molecular imaging of the brain.
IDrugs. 2007 Aug;10(8):527-9.
5
[The contribution of nuclear medicine in the diagnosis of depression].
Hell J Nucl Med. 2006 Jan-Apr;9(1):46-8.
6
Will high-resolution/high-sensitivity SPECT ensure that PET is not the only survivor in nuclear medicine during the next decade?
Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):533-5. doi: 10.1007/s00259-008-1026-4. Epub 2009 Jan 14.
7
[The contribution of nuclear medicine procedures in the diagnosis of dementia of Alzheimer's type. Imaging beta amyloid plaques].
Hell J Nucl Med. 2005 Sep-Dec;8(3):187-90.
8
Strategies for using molecular neuroimaging in dementia.
Handb Clin Neurol. 2008;89:87-95. doi: 10.1016/S0072-9752(07)01207-9.
9
Theranostic and nanotheranostic probes in nuclear medicine.
Methods. 2017 Nov 1;130:14-22. doi: 10.1016/j.ymeth.2017.07.004. Epub 2017 Jul 8.
10
[Current and future prospects of nuclear medicine in dementia].
Rinsho Shinkeigaku. 2017 Sep 30;57(9):479-484. doi: 10.5692/clinicalneurol.cn-001016. Epub 2017 Aug 11.
Zotero 插件